Found 22 matching trials
Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors PHASE2 Study evaluating SOM230 in patients with metastatic carcinoid tumors...
Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas PHASE2 There are no available medical treatment options for patients with non-func...
Show More Location
Endocrinology Section - Hospital Universitário Clementino Fraga Filho/Federal University of Rio de Janeiro
Learn More & Join Trial
Pasireotide in the Treatment of Hypoglycemia Following Gastric Bypass Surgery PHASE4 Postprandial hyperinsulinemic hypoglycemia is a well-known and potentially ...
Show More Location
Zealand University Hospital
Learn More & Join Trial
IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus PHASE2 Observe the safety/tolerability and effectiveness in terms of response rate...
Show More Location
Penn State Milton S. Hershey Medical Center
Learn More & Join Trial
Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly PHASE4 The study was designed to investigate the optimal management of hyperglycem...
Show More Location
Diabetes and Endocrine Associates La Mesa Location
Learn More & Join Trial
Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients PHASE2 5 month study comparing SOM230 s.c. and Sandostatin s.c. in acromegalic pat...
Show More Location
Cedars Sinai Medical Center
Learn More & Join Trial
Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease N/A This is a non-interventional, multinational, multi-center post-marketing st...
Show More Location
St Josephs Hospital and Medical Center
Learn More & Join Trial
A Phase l Study to Evaluate the Pharmacokinetics and Safety Pasireotide in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Volunteers PHASE1 The purpose of this study is to assess the effect of renal impairment on th...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease PHASE2 The main purpose of this prospective, multicenter, open-label phase II stud...
Show More Location
University of Alabama at Birmingham The Kirklin Clinic
Learn More & Join Trial
An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly PHASE2 Acromegaly is a rare, serious condition characterized by chronic hypersecre...
Show More Location
Cedars Sinai Medical Center Dept. of Pituitary Ctr.
Learn More & Join Trial